-
1
-
-
64849109410
-
ACCF/AHA 2009 expert consensus document on pulmonary hypertension
-
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol. 2009;53:1573-1619.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1573-1619
-
-
McLaughlin, V.V.1
Archer, S.L.2
Badesch, D.B.3
Barst, R.J.4
Farber, H.W.5
Lindner, J.R.6
Mathier, M.A.7
McGoon, M.D.8
Park, M.H.9
Rosenson, R.S.10
Rubin, L.J.11
Tapson, V.F.12
Varga, J.13
-
2
-
-
4644290657
-
Treatment of pulmonary arterial hypertension
-
Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425-1436.
-
(2004)
N Engl J Med
, vol.351
, pp. 1425-1436
-
-
Humbert, M.1
Sitbon, O.2
Simonneau, G.3
-
3
-
-
0036007307
-
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
-
Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol. 2002;26:194-201.
-
(2002)
Am J Respir Cell Mol Biol
, vol.26
, pp. 194-201
-
-
Clapp, L.H.1
Finney, P.2
Turcato, S.3
Tran, S.4
Rubin, L.J.5
Tinker, A.6
-
4
-
-
2942541475
-
Cellular and molecular pathobiology of pulmonary arterial hypertension
-
Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(suppl S):13S-24S.
-
(2004)
J Am Coll Cardiol
, vol.43
, Issue.SUPPL. S
-
-
Humbert, M.1
Morrell, N.W.2
Archer, S.L.3
Stenmark, K.R.4
MacLean, M.R.5
Lang, I.M.6
Christman, B.W.7
Weir, E.K.8
Eickelberg, O.9
Voelkel, N.F.10
Rabinovitch, M.11
-
5
-
-
0019985926
-
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension
-
Rubin LJ, Groves BM, Reeves JT, Frosolono M, Handel F, Cato AE. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation. 1982;66:334-338.
-
(1982)
Circulation
, vol.66
, pp. 334-338
-
-
Rubin, L.J.1
Groves, B.M.2
Reeves, J.T.3
Frosolono, M.4
Handel, F.5
Cato, A.E.6
-
6
-
-
0030031888
-
Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
-
Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jöbsis MM, Blackburn SD, Shortino D, Crow JW; Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296-301.
-
(1996)
N Engl J Med
, vol.334
, pp. 296-301
-
-
Barst, R.J.1
Rubin, L.J.2
Long, W.A.3
McGoon, M.D.4
Rich, S.5
Badesch, D.B.6
Groves, B.M.7
Tapson, V.F.8
Bourge, R.C.9
Brundage, B.H.10
Koerner, S.K.11
Langleben, D.12
Keller, C.A.13
Murali, S.14
Uretsky, B.F.15
Clayton, L.M.16
Jöbsis, M.M.17
Blackburn, S.D.18
Shortino, D.19
Crow, J.W.20
more..
-
7
-
-
0037086133
-
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A doubleblind, randomized, placebo-controlled trial
-
Treprostinil Study Group
-
Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a doubleblind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800-804.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 800-804
-
-
Simonneau, G.1
Barst, R.J.2
Galie, N.3
Naeije, R.4
Rich, S.5
Bourge, R.C.6
Keogh, A.7
Oudiz, R.8
Frost, A.9
Blackburn, S.D.10
Crow, J.W.11
Rubin, L.J.12
-
8
-
-
2942549282
-
Prostanoid therapy for pulmonary arterial hypertension
-
Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(suppl S):56S-61S.
-
(2004)
J Am Coll Cardiol
, vol.43
, Issue.SUPPL. S
-
-
Badesch, D.B.1
McLaughlin, V.V.2
Delcroix, M.3
Vizza, C.D.4
Olschewski, H.5
Sitbon, O.6
Barst, R.J.7
-
9
-
-
33750330689
-
Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension
-
Tapson VF, McLaughlin VV, Gomberg-Maitland M, Widlitz AC, Krichman AD, Laliberte KJ, Zaccardelli DS, Barst RJ. Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension. J Vasc Access. 2006;7:112-117.
-
(2006)
J Vasc Access
, vol.7
, pp. 112-117
-
-
Tapson, V.F.1
McLaughlin, V.V.2
Gomberg-Maitland, M.3
Widlitz, A.C.4
Krichman, A.D.5
Laliberte, K.J.6
Zaccardelli, D.S.7
Barst, R.J.8
-
10
-
-
74849116556
-
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial
-
TRUST Study Group
-
Hiremath J, Thanikachalam S, Parikh K, Shanmugasundaram S, Bangera S, Shapiro L, Pott GB, Vnencak-Jones CL, Arneson C, Wade M, White RJ; TRUST Study Group. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial. J Heart Lung Transplant. 2010;29:137-149.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 137-149
-
-
Hiremath, J.1
Thanikachalam, S.2
Parikh, K.3
Shanmugasundaram, S.4
Bangera, S.5
Shapiro, L.6
Pott, G.B.7
Vnencak-Jones, C.L.8
Arneson, C.9
Wade, M.10
White, R.J.11
-
12
-
-
0032810972
-
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
-
Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med. 1999;160:600-607.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 600-607
-
-
Olschewski, H.1
Ghofrani, H.A.2
Walmrath, D.3
Schermuly, R.4
Temmesfeld-Wollbruck, B.5
Grimminger, F.6
Seeger, W.7
-
13
-
-
0036682273
-
Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension
-
Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-329.
-
(2002)
N Engl J Med
, vol.347
, pp. 322-329
-
-
Olschewski, H.1
Simonneau, G.2
Galiè, N.3
Higenbottam, T.4
Naeije, R.5
Rubin, L.J.6
Nikkho, S.7
Speich, R.8
Hoeper, M.M.9
Behr, J.10
Winkler, J.11
Sitbon, O.12
Popov, W.13
Ghofrani, H.A.14
Manes, A.15
Kiely, D.G.16
Ewert, R.17
Meyer, A.18
Corris, P.A.19
Delcroix, M.20
Gomez-Sanchez, M.21
Siedentop, H.22
Seeger, W.23
more..
-
14
-
-
33748931278
-
Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
-
Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol. 2006;48: 1433-1437.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1433-1437
-
-
Channick, R.N.1
Olschewski, H.2
Seeger, W.3
Staub, T.4
Voswinckel, R.5
Rubin, L.J.6
-
15
-
-
33845526777
-
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
-
McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;174:1257-1263.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 1257-1263
-
-
McLaughlin, V.V.1
Oudiz, R.J.2
Frost, A.3
Tapson, V.F.4
Murali, S.5
Channick, R.N.6
Badesch, D.B.7
Barst, R.J.8
Hsu, H.H.9
Rubin, L.J.10
-
16
-
-
77952301237
-
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: A randomized controlled clinical trial
-
McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol. 2010;55:1915-1922.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1915-1922
-
-
McLaughlin, V.V.1
Benza, R.L.2
Rubin, L.J.3
Channick, R.N.4
Voswinckel, R.5
Tapson, V.F.6
Robbins, I.M.7
Olschewski, H.8
Rubenfire, M.9
Seeger, W.10
-
17
-
-
80655137697
-
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension
-
Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant. 2011;30:1327-1333.
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 1327-1333
-
-
Benza, R.L.1
Seeger, W.2
McLaughlin, V.V.3
Channick, R.N.4
Voswinckel, R.5
Tapson, V.F.6
Robbins, I.M.7
Olschewski, H.8
Rubin, L.J.9
-
18
-
-
0036569119
-
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial
-
Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group
-
Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002;39:1496-1502.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1496-1502
-
-
Galiè, N.1
Humbert, M.2
Vachiéry, J.L.3
Vizza, C.D.4
Kneussl, M.5
Manes, A.6
Sitbon, O.7
Torbicki, A.8
Delcroix, M.9
Naeije, R.10
Hoeper, M.11
Chaouat, A.12
Morand, S.13
Besse, B.14
Simonneau, G.15
-
19
-
-
0038037766
-
Beraprost therapy for pulmonary arterial hypertension
-
Beraprost Study Group
-
Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R; Beraprost Study Group. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:2119-2125.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 2119-2125
-
-
Barst, R.J.1
McGoon, M.2
McLaughlin, V.3
Tapson, V.4
Rich, S.5
Rubin, L.6
Wasserman, K.7
Oudiz, R.8
Shapiro, S.9
Robbins, I.M.10
Channick, R.11
Badesch, D.12
Rayburn, B.K.13
Flinchbaugh, R.14
Sigman, J.15
Arneson, C.16
Jeffs, R.17
-
20
-
-
12244251412
-
Efficacy and safety of treprostinil: An epoprostenol analog for primary pulmonary hypertension
-
Treprostinil Study Group
-
McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol. 2003;41:293-299.
-
(2003)
J Cardiovasc Pharmacol
, vol.41
, pp. 293-299
-
-
McLaughlin, V.V.1
Gaine, S.P.2
Barst, R.J.3
Oudiz, R.J.4
Bourge, R.C.5
Frost, A.6
Robbins, I.M.7
Tapson, V.F.8
McGoon, M.D.9
Badesch, D.B.10
Sigman, J.11
Roscigno, R.12
Blackburn, S.D.13
Arneson, C.14
Rubin, L.J.15
Rich, S.16
-
22
-
-
84873570634
-
-
Remodulin (treprostinil) injection solution Research Triangle Park, NC: United Therapeutics Corp
-
Remodulin (treprostinil) injection solution [US Food and Drug Administration drug product label]. Research Triangle Park, NC: United Therapeutics Corp; 2011.
-
(2011)
US Food and Drug Administration Drug Product Label
-
-
-
23
-
-
77953805065
-
Sustained plasma concentrations of treprostinil following chronic dosing of oral treprostinil in patients with pulmonary arterial hypertension
-
Abstract
-
White RJ, Allen R, Torres F, Jerjes C, Pulido T, Carroll J, Yehle D, Laliberte K, Mottola D, Galie N, Simonneau G, Tapson VF. Sustained plasma concentrations of treprostinil following chronic dosing of oral treprostinil in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;179:A3360. Abstract.
-
(2009)
Am J Respir Crit Care Med
, vol.179
-
-
White, R.J.1
Allen, R.2
Torres, F.3
Jerjes, C.4
Pulido, T.5
Carroll, J.6
Yehle, D.7
Laliberte, K.8
Mottola, D.9
Galie, N.10
Simonneau, G.11
Tapson, V.F.12
-
24
-
-
84871548536
-
Overview of the drug-drug interaction potential with treprostinil
-
Abstract
-
Rollins K, Laliberte K, Gotzkowsky K, Wade M, Mottola D. Overview of the drug-drug interaction potential with treprostinil. Am J Respir Crit Care Med. 2009;179:A3367. Abstract.
-
(2009)
Am J Respir Crit Care Med
, vol.179
-
-
Rollins, K.1
Laliberte, K.2
Gotzkowsky, K.3
Wade, M.4
Mottola, D.5
-
25
-
-
77953795218
-
Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers
-
Gotzkowsky SK, Dingemanse J, Lai A, Mottola D, Laliberte K. Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers. J Clin Pharmacol. 2010;50:829-834.
-
(2010)
J Clin Pharmacol
, vol.50
, pp. 829-834
-
-
Gotzkowsky, S.K.1
Dingemanse, J.2
Lai, A.3
Mottola, D.4
Laliberte, K.5
-
26
-
-
84866515810
-
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial
-
Tapson VF, Torres F, Kermeen F, Keogh A, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galie N. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Chest. 2012;142:1383-1390.
-
(2012)
Chest
, vol.142
, pp. 1383-1390
-
-
Tapson, V.F.1
Torres, F.2
Kermeen, F.3
Keogh, A.4
Allen, R.P.5
Frantz, R.P.6
Badesch, D.B.7
Frost, A.E.8
Shapiro, S.M.9
Laliberte, K.10
Sigman, J.11
Arneson, C.12
Galie, N.13
-
27
-
-
37349045123
-
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion
-
McSwain CS, Benza R, Shapiro S, Hill N, Schilz R, Elliott CG, Zwicke DL, Oudiz RJ, Staszewski JP, Arneson CP, Wade M, Zaccardelli D, McLaughlin V. Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. J Clin Pharmacol. 2008;48:19-25.
-
(2008)
J Clin Pharmacol
, vol.48
, pp. 19-25
-
-
McSwain, C.S.1
Benza, R.2
Shapiro, S.3
Hill, N.4
Schilz, R.5
Elliott, C.G.6
Zwicke, D.L.7
Oudiz, R.J.8
Staszewski, J.P.9
Arneson, C.P.10
Wade, M.11
Zaccardelli, D.12
McLaughlin, V.13
-
28
-
-
84872339756
-
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension
-
Published online before print September13 doi:10.1111/1755-5922.12008 Accessed September 1 2012
-
Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther. Published online before print September13, 2012. doi:10.1111/1755-5922.12008. http://onlinelibrary.wiley.com/ doi/10.1111/1755-5922.12008/abstra ct;jsessionid= D66F045CD8BDD338066B5F2A5ECD9A84.d04t01. Accessed September 1, 2012.
-
(2012)
Cardiovasc Ther
-
-
Bourge, R.C.1
Tapson, V.F.2
Safdar, Z.3
Benza, R.L.4
Channick, R.N.5
Rosenzweig, E.B.6
Shapiro, S.7
White, R.J.8
McSwain, C.S.9
Gotzkowsky, S.K.10
Nelsen, A.C.11
Rubin, L.J.12
-
29
-
-
0037149718
-
Bosentan therapy for pulmonary arterial hypertension
-
Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346: 896-903.
-
(2002)
N Engl J Med
, vol.346
, pp. 896-903
-
-
Rubin, L.J.1
Badesch, D.B.2
Barst, R.J.3
Galie, N.4
Black, C.M.5
Keogh, A.6
Pulido, T.7
Frost, A.8
Roux, S.9
Leconte, I.10
Landzberg, M.11
Simonneau, G.12
-
30
-
-
26444534291
-
Sildenafil citrate therapy for pulmonary arterial hypertension
-
Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
-
Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148-2157.
-
(2005)
N Engl J Med
, vol.353
, pp. 2148-2157
-
-
Galiè, N.1
Ghofrani, H.A.2
Torbicki, A.3
Barst, R.J.4
Rubin, L.J.5
Badesch, D.6
Fleming, T.7
Parpia, T.8
Burgess, G.9
Branzi, A.10
Grimminger, F.11
Kurzyna, M.12
Simonneau, G.13
-
31
-
-
46449124591
-
Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) study 1 and 2
-
Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
-
Galiè N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Gerber MJ, Dufton C, Wiens BL, Rubin LJ; Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010-3019.
-
(2008)
Circulation
, vol.117
, pp. 3010-3019
-
-
Galiè, N.1
Olschewski, H.2
Oudiz, R.J.3
Torres, F.4
Frost, A.5
Ghofrani, H.A.6
Badesch, D.B.7
McGoon, M.D.8
McLaughlin, V.V.9
Roecker, E.B.10
Gerber, M.J.11
Dufton, C.12
Wiens, B.L.13
Rubin, L.J.14
-
32
-
-
67649523052
-
Tadalafil therapy for pulmonary arterial hypertension
-
Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group
-
Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894-2903.
-
(2009)
Circulation
, vol.119
, pp. 2894-2903
-
-
Galiè, N.1
Brundage, B.H.2
Ghofrani, H.A.3
Oudiz, R.J.4
Simonneau, G.5
Safdar, Z.6
Shapiro, S.7
White, R.J.8
Chan, M.9
Beardsworth, A.10
Frumkin, L.11
Barst, R.J.12
-
33
-
-
80051540466
-
Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era
-
Zhang R, Dai LZ, Xie WP, Yu ZX, Wu BX, Pan L, Yuan P, Jiang X, He J, Humbert M, Jing ZC. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era. Chest. 2011;140:301-309.
-
(2011)
Chest
, vol.140
, pp. 301-309
-
-
Zhang, R.1
Dai, L.Z.2
Xie, W.P.3
Yu, Z.X.4
Wu, B.X.5
Pan, L.6
Yuan, P.7
Jiang, X.8
He, J.9
Humbert, M.10
Jing, Z.C.11
-
34
-
-
34548033284
-
Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension
-
Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, Wang ZW, Cheng XS, Xu B, Hu SS, Hui RT, Yang YJ. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132:373-379.
-
(2007)
Chest
, vol.132
, pp. 373-379
-
-
Jing, Z.C.1
Xu, X.Q.2
Han, Z.Y.3
Wu, Y.4
Deng, K.W.5
Wang, H.6
Wang, Z.W.7
Cheng, X.S.8
Xu, B.9
Hu, S.S.10
Hui, R.T.11
Yang, Y.J.12
-
35
-
-
80051559475
-
Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled study
-
Jing ZC, Yu ZX, Shen JY, Wu BX, Xu KF, Zhu XY, Pan L, Zhang ZL, Liu XQ, Zhang YS, Jiang X, Galiè N; Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2011;183:1723-1729.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 1723-1729
-
-
Jing, Z.C.1
Yu, Z.X.2
Shen, J.Y.3
Wu, B.X.4
Xu, K.F.5
Zhu, X.Y.6
Pan, L.7
Zhang, Z.L.8
Liu, X.Q.9
Zhang, Y.S.10
Jiang, X.11
Galiè, N.12
-
36
-
-
84855163346
-
The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: An open-label prospective multicenter study [in Chinese]
-
National Bosentan Therapy for PAH Study Group
-
Dai LZ, Jiang X, Wang Y, Yu ZX, Yao H, Wang GY, Wu BX, Jing ZC; National Bosentan Therapy for PAH Study Group. The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: an open-label, prospective multicenter study [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:124-127.
-
(2011)
Zhonghua Xin Xue Guan Bing Za Zhi
, vol.39
, pp. 124-127
-
-
Dai, L.Z.1
Jiang, X.2
Wang, Y.3
Yu, Z.X.4
Yao, H.5
Wang, G.Y.6
Wu, B.X.7
Jing, Z.C.8
|